Get 40% Off
😲 Missed the +20.8% surge in our stock strategy last month? Not again! Get premium insightsGet 40% Off Now

Bioverativ Inc (BIVV)

NASDAQ
Currency in USD
Disclaimer
104.98
0.00(0.00%)
Closed
Fair Value
Unlock Value
Day's Range
104.97105.01
52 wk Range
0.00105.01
Prev. Close
104.65
Open
104.97
Day's Range
104.97-105.01
52 wk Range
0-0
Volume
0
Average Vol. (3m)
2,179,375
1-Year Change
0%
Shares Outstanding
107,952,005
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about BIVV?
Vote to see community's results!
or
  • Notable earnings after Tuesday’s close
    • BySeeking Alpha
  • Nasdaq Biotech Index: 54 to be added, 15 removed
    • BySeeking Alpha

Bioverativ Inc Company Profile

Bioverativ Inc. is a biopharmaceutical company that engages in the development of therapies and programs for hemophilia, cold agglutinin disease, sickle cell disease, beta thalassemia, and other blood disorders. Its pipeline includes hemophilia programs that provide less-frequent prophylactic dosing for hemophilia A and subcutaneous dosing for hemophilia B; and gene therapy programs for hemophilia A and B. The company also includes programs to address cold agglutinin disease, a rare and chronic autoimmune hemolytic condition; and Sutimlimab (formerly BIVV009), a therapy in development that is designed to selectively inhibit the complement pathway of the immune system. Bioverativ Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts. Bioverativ Inc. operates as a subsidiary of Sanofi.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.